Baillie Gifford & Co Portfolio holdings
Baillie Gifford & Co., founded in 1908 by Lt Col Augustus Baillie and Carlyle Gifford and headquartered in Edinburgh, Scotland, is an independent, partnership-owned investment management firm renowned for its long-term, growth-oriented approach, managing over £230 billion ($290 billion USD) in assets as of late 2024. Focusing primarily on global equities, the firm serves institutional clients like pension funds and retail investors through mutual funds and investment trusts, such as the Scottish Mortgage Investment Trust, emphasizing fundamental research into innovative, high-growth companies—often holding stakes in firms like Tesla and Amazon for decades. With around 2,000 employees across offices in London, New York, Hong Kong, and beyond, Baillie Gifford operates without external ownership pressures, allowing its 58 partners to prioritize patience and conviction over short-term market trends. Known for its low-profile culture and ESG integration, the firm has earned a reputation as a thoughtful, contrarian investor in a world of rapid-fire trading.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
e.l.f. Beauty
ELF
|
+$676M |
| 2 |
UnitedHealth
UNH
|
+$402M |
| 3 |
AutoZone
AZO
|
+$339M |
| 4 |
Kaspi.kz JSC
KSPI
|
+$269M |
| 5 |
Enphase Energy
ENPH
|
+$268M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
NVIDIA
NVDA
|
+$2.12B |
| 2 |
Spotify
SPOT
|
+$1.61B |
| 3 |
Tesla
TSLA
|
+$619M |
| 4 |
Teradyne
TER
|
+$540M |
| 5 |
Shopify
SHOP
|
+$408M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Consumer Discretionary | 29.35% |
| 2 | Technology | 27.26% |
| 3 | Communication Services | 14.16% |
| 4 | Healthcare | 13.89% |
| 5 | Financials | 6.23% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
201
CarMax
KMX
$8.24B
| $12.7M | 0.01% |
173,390
+35,451
| +26% | +$2.55M |
|
202
Nike
NKE
$62.3B
| $12.4M | 0.01% |
164,852
+48
| +0% | +$4.46K |
|
203
Ionis Pharmaceuticals
IONS
$9.06B
| $12.4M | 0.01% |
260,254
-35,429
| -12% | -$1.45M |
|
204
Blackstone Secured Lending
BXSL
$5.62B
| $12.2M | 0.01% |
+398,415
| New | +$12.5M |
|
205
Estee Lauder
EL
$30.9B
| $11.6M | 0.01% |
109,022
-2,137
| -2% | -$280K |
|
206
QuantumScape Corp
QS
$3.4B
| $11.5M | 0.01% |
2,332,682
-346,836
| -13% | -$1.93M |
|
207
Graco
GGG
$13.5B
| $10.8M | 0.01% |
135,794
| – | – |
|
208
WEC Energy
WEC
$35.2B
| $10.6M | 0.01% |
135,621
-29,893
| -18% | -$2.43M |
|
209
Paycom
PAYC
$10.1B
| $10.6M | 0.01% |
+74,042
| New | +$12.7M |
|
210
Sun Communities
SUI
$14.7B
| $10.4M | 0.01% |
86,691
-25,342
| -23% | -$3.01M |
|
|
DCBO
211
Docebo
DCBO
$520M
| $10.2M | 0.01% |
264,234
+41,965
| +19% | +$1.72M |
|
212
Installed Building Products
IBP
$6.52B
| $10.1M | 0.01% |
48,993
| – | – |
|
213
dLocal
DLO
$4.35B
| $10.1M | 0.01% |
1,243,991
-302,100
| -20% | -$3.55M |
|
214
ResMed
RMD
$32.4B
| $10.1M | 0.01% |
52,559
-7,073
| -12% | -$1.44M |
|
215
PayPal
PYPL
$51.1B
| $9.78M | 0.01% |
168,489
+9
| +0% | +$572 |
|
216
Ascendis Pharma A/S
ASND
$16.4B
| $9.69M | 0.01% |
71,071
-10,135
| -12% | -$1.38M |
|
217
Veeva Systems
VEEV
$35.4B
| $9.18M | 0.01% |
50,154
-7,081
| -12% | -$1.41M |
|
218
Fortis
FTS
$28.6B
| $9.11M | 0.01% |
234,386
-83,573
| -26% | -$3.3M |
|
219
Tandem Diabetes Care
TNDM
$1.29B
| $8.96M | 0.01% |
222,386
-37,311
| -14% | -$1.56M |
|
220
EverQuote
EVER
$839M
| $8.85M | 0.01% |
424,183
-352,068
| -45% | -$7.44M |
|
221
Sixth Street Specialty
TSLX
$1.78B
| $8.75M | 0.01% |
410,054
+184,634
| +82% | +$3.93M |
|
222
Codexis
CDXS
$159M
| $8.4M | 0.01% |
2,708,802
-736,507
| -21% | -$2.37M |
|
223
Quanterix
QTRX
$180M
| $8.37M | 0.01% |
633,460
+10,105
| +2% | +$169K |
|
224
Compañía de Cervecerías Unidas
CCU
$2.21B
| $8M | 0.01% |
702,978
-57,492
| -8% | -$707K |
|
225
Golub Capital BDC
GBDC
$3.39B
| $7.95M | 0.01% |
505,959
+198,473
| +65% | +$3.26M |
|
Similar funds
Baillie Gifford & Co's Q2 2024 Portfolio in Review
As of Q2 2024, Baillie Gifford & Co held 303 positions worth $128B, down 0.15% from $129B the previous quarter. Its ten largest holdings account for 42% of the portfolio.
Baillie Gifford & Co withdrew a net $5.32B in Q2 2024, closing 18 positions and reducing 164 holdings. Its most notable exit was Baidu, an estimated $271M position sold in full.
By sector, the portfolio is most concentrated in Consumer Discretionary at 29% of assets, up from 27% a quarter earlier, followed by Technology and Communication Services.
Against the trend, Baillie Gifford & Co opened a new position in e.l.f. Beauty worth $802M.
- Baillie Gifford & Co's largest Q2 2024 buy was e.l.f. Beauty: 3,804,541 shares worth $802M.
- Baillie Gifford & Co added most to UnitedHealth in Q2 2024, an estimated $402M increase.
- Baillie Gifford & Co's biggest Q2 2024 reduction was NVIDIA, cutting an estimated $2.12B.
- Baillie Gifford & Co fully exited Baidu in Q2 2024, selling an estimated $271M.
- Baillie Gifford & Co's ten largest holdings make up 42% of its $128B portfolio in Q2 2024.
- Baillie Gifford & Co opened 13 new positions and closed 18 in Q2 2024.
- Baillie Gifford & Co's portfolio value fell 0.15% quarter-over-quarter to $128B.
Based on Baillie Gifford & Co's 13F filing for Q2 2024, filed 25 Jul 2024.